About the Event
AMGA Foundation, with support from Amgen and Novartis, launched a 15-month initiative focused on helping medical groups develop strategies to improve the management and treatment of patients with established atherosclerotic cardiovascular disease (ASCVD).The ASCVD Best Practices Learning Collaborative was designed to provide a platform for participating organizations to improve their clinical performance in the treatment of established ASCVD through the development and implementation of quality improvement projects, best practice sharing, and peer-to-peer learning.
This webinar will provide the Collaborative's lesson's learned, highlighting three participating organizations and their data.